Citric Acid, Anhydrous, Powder, U.S.P., Multi-Compendial, J.T.Baker®
You have not viewed any products recently.
- There are no alternate images available for this product.
- There are no alternate images available for this product.
Citric Acid, Anhydrous, Powder, U.S.P., Multi-Compendial, J.T.Baker®
Formula: HOC(COOH)(CH2COOH)2
Formula Weight: 192.12
| TEST |
SPECIFICATION |
| GMP Manufactured Product |
| Meets B.P.; E.P.; J.P. Chemical Specifications; Meets U.S.P Requirements |
| Preserve in Tight Containers |
| CAUTION: For Manufacturing, processing or repackaging |
| Bulk Pharmaceutical Chemical |
| USP - Assay (HOC(COOH)(CH2COOH)2) (anhydrous basis) |
99.5 - 100.5% |
| USP - Clarity of Solution |
Passes Test |
| USP - Color of Solution |
Passes Test |
| USP - Identification |
Passes Test |
| USP - Residue on Ignition |
<= 0.1% |
| USP - Oxalic Acid |
<= 0.036% |
| USP - Sulfate (SO4) |
<= 0.015% |
| USP - Readily Carbonizable Substances |
Passes Test |
| USP - Identification C: Water (H2O) |
<= 1.0% |
| EP/BP - Assay (HOC(COOH)(CH2COOH)2) (anhydrous basis) |
99.5 - 100.5% |
| EP/BP - Identification B |
Passes Test |
| EP/BP - Identification E |
Passes Test |
| EP/BP - Appearance of Solution |
Passes Test |
| EP/BP - Readily Carbonizable Substances |
Passes Test |
| EP/BP - Oxalic Acid |
<= 360 ppm |
| EP/BP - Sulfate (SO4) |
<= 150 ppm |
| EP/BP - Water (H2O) |
<= 1.0% |
| EP/BP - Ash (sulfated) |
<= 0.1% |
| EP/BP - Endotoxin Concentration, <0.5 IU/mg |
Passes Test |
| JP - Assay (HOC(COOH)(CH2COOH)2) (anhydrous basis) |
99.5 - 100.5% |
| JP - Clarity and Color of Solution |
Passes Test |
| JP - Identification |
Passes Test |
| JP - Sulfate (SO4) |
<= 150 ppm |
| JP - Oxalic Acid |
<= 360 ppm |
| JP - Heavy Metals (as Pb) |
<= 10 ppm |
| JP - Readily Carbonizable Substances |
Passes Test |
| JP - Residue on Ignition |
<= 0.10% |
| JP - Water (H2O) |
<= 1.0% |
| Total Aerobic Microbial Count, For Information Only |
| Total Yeasts and Molds Count, For Information Only |
| E. coli |
Negative |
| P. aureginosa |
Negative |
| Must be subjected to further processing during the preparation of injectable dosage forms |
| No Class 1,2,3 or other solvents are used or produced in the manufacturing or purification of the product. |